ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

JANX Janux Therapeutics Inc

47.39
0.29 (0.62%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Janux Therapeutics Inc JANX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.29 0.62% 47.39 09:34:00
Open Price Low Price High Price Close Price Previous Close
47.08 46.51 48.23 47.39 47.10
more quote information »

Recent News

Date Time Source Heading
09/3/202408:47EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/3/202408:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
09/3/202408:11EDGAR2Form 8-K - Current report
09/3/202408:01BWJanux Therapeutics Reports Fourth Quarter and Full Year 2023..
01/3/202409:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
01/3/202409:11EDGAR2Form 8-K - Current report
29/2/202417:22BWJanux Therapeutics Announces Pricing of $296.5 Million..
29/2/202413:55EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
29/2/202409:15EDGAR2Form 8-K - Current report
28/2/202413:50EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/2/202409:23EDGAR2Form 8-K - Current report
28/2/202409:00BWJanux Therapeutics Announces Proposed Public Offering of..
27/2/202408:05BWJanux Announces Encouraging Safety and Efficacy Data in..
21/2/202400:00BWJanux Therapeutics to Host Virtual Event Discussing Updated..
10/2/202408:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202408:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/1/202401:00BWJanux Therapeutics Promotes Co-Founder Tommy DiRaimondo,..
04/1/202408:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202408:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202408:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202408:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202408:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202408:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/11/202308:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202308:07EDGAR2Form 8-K - Current report
08/11/202308:01BWJanux Therapeutics Reports Third Quarter 2023 Financial..
08/9/202308:14EDGAR2Form 144 - Report of proposed sale of securities
15/8/202306:33EDGAR2Form 144 - Report of proposed sale of securities
09/8/202306:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202306:17EDGAR2Form 8-K - Current report
09/8/202306:01BWJanux Therapeutics Reports Second Quarter 2023 Financial..
19/7/202307:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/7/202306:16EDGAR2Form 8-K - Current report
17/7/202322:45BWJanux Therapeutics Announces Pricing of $60 Million..
17/7/202322:16EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
17/7/202322:06EDGAR2Form 8-K - Current report
17/7/202322:00BWJanux Therapeutics Announces Positive Interim Clinical Data..
06/6/202306:35BWJanux Therapeutics Appoints Zachariah McIver, D.O., Ph.D.,..
10/5/202306:01BWJanux Therapeutics Reports First Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock